...
机译:厄洛替尼的I期临床试验用于非渐进性胶质母细胞瘤多形式放射治疗,复发性恶性神经胶质瘤和脑膜瘤
Department of Neurology, Feinberg School of Medicine, Northwestern University, 710 North Lake Shore Drive, Abbott Hall, 1123, Chicago, IL 60611;
Memorial Sloan-Kettering Cancer Center, New York, New York;
rnMemorial Sloan-Kettering Cancer Center, New York, New York;
rnDepartment of Neurological Surgery, University of California-San Francisco, San Francisco, California;
Department of Neurological Surgery, University of California-San Francisco, San Francisco, California;
Pharmacotherapy Education and Research Center, University of Texas Health Science Center San Antonio, San Antonio, Texas;
rnDepartment of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
rnDepartment of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
rnDepartment of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
rnDana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts;
rnNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;
rnUniversity of Wisconsin Hospital, Madison, Wisconsin;
Memorial Sloan-Kettering Cancer Center, New York, New York;
rnDivision of Neuro-Oncology, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, Pittsburgh;
Neuro-Oncology Program, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California;
rnUniversity of Wisconsin Hospital, Madison, Wisconsin;
Ontario Institute for Cancer Research, Toronto, Ontario, Canada;
rnDepartment of Neurological Surgery, University of California-San Francisco, San Francisco, California;
erlotinib; glioblastoma; glioma; meningioma; pharmacokinetics;
机译:厄洛替尼的II期临床试验用于复发性恶性神经胶质瘤和多发性胶质母细胞瘤的放射治疗
机译:厄洛替尼和西罗莫司治疗复发性恶性神经胶质瘤的Ⅰ/Ⅱ期研究:北美脑肿瘤联合试验04-02
机译:厄洛替尼联合放射治疗多形性胶质母细胞瘤患者的I期试验:北中部癌症治疗组协议N0177的结果。
机译:用近距离放射治疗IR 192 HDR方法治疗的患者的脑部脑磁共振光谱(HL-MRS)对脑病的分化性质坏死和胶质瘤复发性
机译:一种用于恶性神经胶质瘤定量层次图像分析的自动化系统:开发强大的技术,用于对多种胶质母细胞瘤进行整合的细分/分类和预后。
机译:厄洛替尼的I期临床试验用于非渐进性胶质母细胞瘤多形式放射治疗复发性恶性神经胶质瘤和脑膜瘤
机译:厄洛替尼的I期临床试验用于非渐进性胶质母细胞瘤多形式放射治疗,复发性恶性神经胶质瘤和脑膜瘤†